Melvyn T. Chow

5.6k citations

16 papers · 3.4k indexed · 3 hit papers · h-index 16

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Chemokine receptors and signaling

Papers in

Immunology 15
- Immune Cell Function and Interaction 12
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 4
- IL-33, ST2, and ILC Pathways 2
Physiology 1

Co-authors: Andrew D. Luster Mark J. Smyth Aleksandra J. Ozga Andreas Möller Paul A. Beavis Liza B. John Christel Devaud Phillip K. Darcy
Journals: Immunology and Cell Biology (3 papers)Immunity (3 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)
Partner nations: Australia United States France

In The Last Decade

Melvyn T. Chow

16 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Chemokines and the immune response to cancer 2021 · 480 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Immunity
2019 Immunity
2013 Clinical Cancer Research

Peers

Countries citing papers authored by Melvyn T. Chow

Since Specialization

Citations

This map shows the geographic impact of Melvyn T. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvyn T. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvyn T. Chow more than expected).

Fields of papers citing papers by Melvyn T. Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvyn T. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvyn T. Chow. The network helps show where Melvyn T. Chow may publish in the future.

Co-authors

The 25 scholars most cited alongside Melvyn T. Chow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melvyn T. Chow Line = papers co-authored together Melvyn T. Chow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection Immunity ·Aleksandra J. Ozga, Melvyn T. Chow, Mateus Eustáquio Lopes, Rachel L. Servis, Mauro Di Pilato, Philippe Dehio, Jeffrey Lian, Thorsten R. Mempel, Andrew D. Luster	2021	52
2	Chemokines and the immune response to cancer Immunity ·Aleksandra J. Ozga, Melvyn T. Chow, Andrew D. Luster Hit paper breakdown →	2021	480
3	Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy Immunity ·Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, Dennie T. Frederick, Jennifer A. Lo, David E. Fisher, Gordon J. Freeman, Genevieve M. Boland, Andrew D. Luster Hit paper breakdown →	2019	438
4	Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis OncoImmunology ·Camille Guillerey, Melvyn T. Chow, Kim Miles, Stuart D. Olver, Jaclyn Sceneay, Kazuyoshi Takeda, Andreas Möller, Mark J. Smyth	2015	35
5	The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions Nature Immunology ·Christopher J. Chan, Ludovic Martinet, Susan Gilfillan, Fernando Souza-Fonseca-Guimarães, Melvyn T. Chow, Liam Town, David Ritchie, Marco Colonna, Daniel M. Andrews, Mark J. Smyth	2014	365
6	CD3^bright signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1⁺ T cells Immunology and Cell Biology ·Christophe Paget, Melvyn T. Chow, Nicholas A. Gherardin, Paul A. Beavis, Adam P. Uldrich, Helene Duret, Maya Hassane, Fernando Souza-Fonseca-Guimarães, Denis A. Mogilenko, D. Staumont‐Sallé, Nichole Escalante, Geoffrey R. Hill, Paul J. Neeson, David Ritchie, David Dombrowicz, Thierry Mallevaey, François Trottein, Gabrielle T. Belz, Dale I. Godfrey, Mark J. Smyth	2014	65
7	Chemokines in Cancer Cancer Immunology Research ·Melvyn T. Chow, Andrew D. Luster	2014	384
8	Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP3 inflammasome priming European Journal of Immunology ·Melvyn T. Chow, Helene Duret, Daniel M. Andrews, Christelle Faveeuw, Andreas Möller, Mark J. Smyth, Christophe Paget	2014	21
9	Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells Clinical Cancer Research ·Liza B. John, Christel Devaud, Connie P.M. Duong, Carmen S. Yong, Paul A. Beavis, Nicole M. Haynes, Melvyn T. Chow, Mark J. Smyth, Michael H. Kershaw, Phillip K. Darcy Hit paper breakdown →	2013	571
10	Blockade of A _2A receptors potently suppresses the metastasis of CD73 ⁺ tumors Proceedings of the National Academy of Sciences ·Paul A. Beavis, Upulie Divisekera, Christophe Paget, Melvyn T. Chow, Liza B. John, Christel Devaud, Karen M. Dwyer, John Stagg, Mark J. Smyth, Phillip K. Darcy	2013	290
11	NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases Cancer Research ·Melvyn T. Chow, Jaclyn Sceneay, Christophe Paget, Christina S.F. Wong, Helene Duret, Jürg Tschopp, Andreas Möller, Mark J. Smyth	2012	155
12	Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche Cancer Research ·Jaclyn Sceneay, Melvyn T. Chow, Anna Chen, Heloise M. Halse, Christina S.F. Wong, Daniel M. Andrews, Erica K. Sloan, Belinda S. Parker, David D.L. Bowtell, Mark J. Smyth, Andreas Möller	2012	296
13	Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity The Journal of Immunology ·Christophe Paget, Melvyn T. Chow, Helene Duret, Stephen R. Mattarollo, Mark J. Smyth	2012	40
14	NLRP3 promotes inflammation‐induced skin cancer but is dispensable for asbestos‐induced mesothelioma Immunology and Cell Biology ·Melvyn T. Chow, Jürg Tschopp, Andreas Möller, Mark J. Smyth	2012	63
15	Inflammation and immune surveillance in cancer Seminars in Cancer Biology ·Melvyn T. Chow, Andreas Möller, Mark J. Smyth	2011	168
16	Homeostatic defects in interleukin 18‐deficient mice contribute to protection against the lethal effects of endotoxin Immunology and Cell Biology ·Daniel M. Andrews, Melvyn T. Chow, Yuting Ma, Claire L Cotterell, Sally V. Watt, Desiree A. Anthony, Shizuo Akira, Yoichiro Iwakura, Joseph A. Trapani, Laurence Zitvogel, Mark J. Smyth	2011	15

About Melvyn T. Chow

Melvyn T. Chow is a scholar working on Immunology, Physiology, Oncology, Dermatology and Molecular Biology, having authored 16 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Immune cells in cancer (6 papers), Immunotherapy and Immune Responses (5 papers), Inflammasome and immune disorders (5 papers), T-cell and B-cell Immunology (4 papers), Chemokine receptors and signaling (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Immunology (2.2k citations), Oncology (2.1k citations), Physiology (196 citations), Cancer Research (304 citations) and Molecular Biology (862 citations). Melvyn T. Chow has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Andrew D. Luster, Mark J. Smyth, Aleksandra J. Ozga, Andreas Möller, Paul A. Beavis, Liza B. John, Christel Devaud, Phillip K. Darcy, Daniel M. Andrews and Christophe Paget. Their work appears in journals such as Immunology and Cell Biology, Immunity, Cancer Research, Clinical Cancer Research and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact